{"id":"https://openalex.org/W242540068","doi":null,"title":"[Survival in patients with clear cell carcinoma of the ovary].","display_name":"[Survival in patients with clear cell carcinoma of the ovary].","publication_year":1998,"publication_date":"1998-01-01","ids":{"openalex":"https://openalex.org/W242540068","mag":"242540068","pmid":"https://pubmed.ncbi.nlm.nih.gov/9464331"},"language":"ja","primary_location":{"id":"pmid:9464331","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9464331","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"English Abstract"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"T Nakano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087637","display_name":"Toyama Prefectural Central Hospital","ror":"https://ror.org/004cah429","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087637"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"T Nakano","raw_affiliation_strings":["Dept. of Obstetrics and Gynecology, Toyama Prefectural Central Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Obstetrics and Gynecology, Toyama Prefectural Central Hospital","institution_ids":["https://openalex.org/I4210087637"]}]},{"author_position":"middle","author":{"id":null,"display_name":"K Enoki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Enoki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027640195","display_name":"Masayuki Nakashima","orcid":"https://orcid.org/0000-0001-8551-2803","observed_orcids":["https://orcid.org/0000-0001-8551-2803"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Nakashima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002119477","display_name":"Hiroshi Ishikawa","orcid":"https://orcid.org/0000-0003-1116-6885","observed_orcids":["https://orcid.org/0000-0003-1116-6885"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Ishikawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020676091","display_name":"Yuka Ametani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y Ametani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109319882","display_name":"Syunsuke Ohta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Ohta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072611312","display_name":"A Ohkuchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Ohkuchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078468961","display_name":"Soichi Satake","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Satake","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025188852","display_name":"Yasushi Kojima","orcid":"https://orcid.org/0000-0002-0087-1768","observed_orcids":["https://orcid.org/0000-0002-0087-1768"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y Kojima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041868476","display_name":"Hiroshi Funamoto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Funamoto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016189311","display_name":"Masatoshi Tateno","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Tateno","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"A Miwa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Miwa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3604,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.63554718,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"25","issue":"1","first_page":"67","last_page":"73"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10390","display_name":"Ovarian function and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-clear-cell-carcinoma","display_name":"ovarian clear cell carcinoma","score":0.984000027179718},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.7129999995231628},{"id":"https://openalex.org/keywords/figo-stage","display_name":"FIGO stage","score":0.7879999876022339},{"id":"https://openalex.org/keywords/p53-expression","display_name":"p53 expression","score":0.921999990940094},{"id":"https://openalex.org/keywords/proliferative-cell-nuclear-antigen","display_name":"proliferative cell nuclear antigen","score":0.8519999980926514},{"id":"https://openalex.org/keywords/proliferative-activity","display_name":"proliferative activity","score":0.7289999723434448},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.7179999947547913},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.996999979019165},{"id":"https://openalex.org/keywords/tumor-recurrence","display_name":"tumor recurrence","score":0.4620000123977661},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7919999957084656}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.634974479675293},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.6279922127723694},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6276401281356812},{"id":"https://openalex.org/C3019054536","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian carcinoma","level":4,"score":0.5720372200012207},{"id":"https://openalex.org/C2781199814","wikidata":"https://www.wikidata.org/wiki/Q18556242","display_name":"Clear cell carcinoma","level":3,"score":0.5580235719680786},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.5219842195510864},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5124557614326477},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.485939621925354},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.465372771024704},{"id":"https://openalex.org/C34688535","wikidata":"https://www.wikidata.org/wiki/Q418732","display_name":"Proliferating cell nuclear antigen","level":3,"score":0.4582045078277588},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.44944313168525696},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43616464734077454},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41950395703315735},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3278990387916565},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10842719674110413},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D018262","descriptor_name":"Adenocarcinoma, Clear Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018262","descriptor_name":"Adenocarcinoma, Clear Cell","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":true},{"descriptor_ui":"D018262","descriptor_name":"Adenocarcinoma, Clear Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D018432","descriptor_name":"Drug Resistance, Multiple","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018809","descriptor_name":"Proliferating Cell Nuclear Antigen","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9464331","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9464331","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gan to kagaku ryoho. Cancer & chemotherapy","raw_type":"English Abstract"},{"id":"mag:242540068","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9464331","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4308806189","https://openalex.org/W2024270592","https://openalex.org/W1983414305","https://openalex.org/W2142657147","https://openalex.org/W2078245598","https://openalex.org/W4253029231","https://openalex.org/W2280778178","https://openalex.org/W2091387226","https://openalex.org/W2390395210","https://openalex.org/W2231639364"],"abstract_inverted_index":{"Thirty-one":[0],"patients":[1,18,32,39,60,72,125,151,169,184,194,236],"with":[2,47,59,73,147,152,170],"clear":[3],"cell":[4,102],"ovarian":[5],"carcinoma":[6],"who":[7,61,174,185,195],"underwent":[8],"primary":[9],"surgery":[10],"and":[11,25,37,43,50,76,85,97,142,160,178],"postoperative":[12],"therapy":[13],"were":[14,89,110,145,157,204],"retrospectively":[15],"evaluated.":[16],"Eighteen":[17],"(58%)":[19],"had":[20,62,186,196],"International":[21],"Federation":[22],"of":[23,107,114,122,134],"Gynecology":[24],"Obstetrics":[26],"(FIGO)":[27],"stage":[28,34,41,48,63,74,153,171],"I":[29,64,154,172],"disease,":[30,36],"3":[31],"(9.7%)":[33],"II":[35,66],"10":[38],"(32.3%)":[40],"III":[42,49,75],"IV":[44,51,77],"disease.":[45],"Patients":[46],"disease":[52,67,78],"demonstrated":[53],"a":[54,155,173],"significantly":[55],"poor":[56,148],"prognosis":[57],"compared":[58],"or":[65,131,198],"(p":[68],"<":[69],"0.01).":[70],"No":[71],"survived":[79],"5":[80,193],"years.":[81],"p53":[82,95,108,140,159,177,219,227,234],"protein":[83],"expression":[84],"proliferative":[86],"activity":[87],"(PA)":[88],"studied":[90],"by":[91],"immunohistochemical":[92],"methods":[93],"using":[94],"molecule":[96],"antibodies":[98],"to":[99,223],"PCNA":[100,129],"(proliferative":[101],"nuclear":[103],"antigen).":[104],"Intranuclear":[105],"accumulations":[106],"product":[109],"observed":[111],"in":[112,221],"15":[113,121],"31":[115,123],"(48.4%).":[116],"On":[117],"the":[118],"other":[119],"hand,":[120],"(48.4%)":[124],"stained":[126,137],"positively":[127],"for":[128,168,183,212],"(>":[130],"=":[132,199],"60%":[133],"cancer":[135],"cells":[136],"positively).":[138],"Positive":[139],"staining":[141],"highly":[143,161,179],"PA":[144],"associated":[146],"survival.":[149],"Two":[150],"relapsed":[156],"positive":[158,176,235],"PA.":[162,180],"Accordingly,":[163],"consolidation":[164],"chemotherapy":[165,182,214],"is":[166],"necessary":[167],"are":[175,237],"Platinum-based":[181],"minimal":[187],"residual":[188],"tumor":[189,202],"was":[190,215],"effective,":[191],"but":[192],">":[197],"2":[200],"cm":[201],"burden":[203],"not":[205],"effective":[206],"at":[207],"all.":[208],"The":[209],"response":[210],"rate":[211],"platinum-based":[213],"20%":[216],"(1/5)":[217],"among":[218,226],"positive,":[220],"contrast":[222],"66.7%":[224],"(4/6)":[225],"negative":[228],"patients.":[229],"So":[230],"it":[231],"seems":[232],"that":[233],"chemoresistant.":[238]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2016-06-24T00:00:00"}